SIMILAR PATTERNS OF AMINO ACIDS FOR 5HW8_F_FK5F201
List of similar pattern of amino acids derived from ASSAM searchHit | Macromolecule/ Organism |
Pfam | Res. | Interface | HETATM | RMSD | Dali Z-score | Seq. Identity (%) | View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1fd9 | PROTEIN (MACROPHAGEINFECTIVITYPOTENTIATOR PROTEIN) (Legionellapneumophila) |
PF00254(FKBP_C)PF01346(FKBP_N) | 6 | TYR A 131ASP A 142VAL A 158ILE A 159TYR A 185PHE A 202 | None | 0.65A | 5hw8B-1fd9A:15.75hw8F-1fd9A:12.85hw8G-1fd9A:15.4 | 5hw8B-1fd9A:23.115hw8F-1fd9A:23.115hw8G-1fd9A:23.11 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1fd9 | PROTEIN (MACROPHAGEINFECTIVITYPOTENTIATOR PROTEIN) (Legionellapneumophila) |
PF00254(FKBP_C)PF01346(FKBP_N) | 6 | TYR A 131VAL A 158ILE A 159TRP A 162TYR A 185PHE A 202 | None | 0.41A | 5hw8B-1fd9A:15.75hw8F-1fd9A:12.85hw8G-1fd9A:15.4 | 5hw8B-1fd9A:23.115hw8F-1fd9A:23.115hw8G-1fd9A:23.11 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1fkk | FK506 BINDINGPROTEIN (Bos taurus) |
PF00254(FKBP_C) | 9 | TYR A 26ASP A 37PHE A 46VAL A 55ILE A 56TRP A 59TYR A 82ILE A 90PHE A 99 | None | 0.62A | 5hw8B-1fkkA:18.85hw8F-1fkkA:15.05hw8G-1fkkA:18.0 | 5hw8B-1fkkA:45.835hw8F-1fkkA:45.835hw8G-1fkkA:45.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1fkk | FK506 BINDINGPROTEIN (Bos taurus) |
PF00254(FKBP_C) | 5 | TYR A 26PHE A 46TRP A 59ILE A 90PHE A 99 | None | 0.92A | 5hw8B-1fkkA:18.85hw8F-1fkkA:15.05hw8G-1fkkA:18.0 | 5hw8B-1fkkA:45.835hw8F-1fkkA:45.835hw8G-1fkkA:45.83 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1gmm | CBM6 (Ruminiclostridiumthermocellum) |
PF03422(CBM_6) | 5 | VAL A 59ILE A 121ILE A 7PHE A 115ILE A 102 | None | 1.05A | 5hw8B-1gmmA:undetectable5hw8F-1gmmA:undetectable5hw8G-1gmmA:undetectable | 5hw8B-1gmmA:21.015hw8F-1gmmA:21.015hw8G-1gmmA:21.01 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1h4p | GLUCAN1,3-BETA-GLUCOSIDASEI/II (Saccharomycescerevisiae) |
PF00150(Cellulase) | 5 | TYR A 297TYR A 67ILE A 68PHE A 300ILE A 407 | GOL A1450 ( 4.8A)GOL A1450 (-4.6A)NoneNoneNone | 1.11A | 5hw8B-1h4pA:undetectable5hw8F-1h4pA:undetectable5hw8G-1h4pA:undetectable | 5hw8B-1h4pA:14.775hw8F-1h4pA:14.775hw8G-1h4pA:14.77 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1jvw | MACROPHAGEINFECTIVITYPOTENTIATOR (Trypanosomacruzi) |
PF00254(FKBP_C) | 5 | PHE A 114ILE A 120TRP A 123TYR A 146PHE A 163 | None | 1.06A | 5hw8B-1jvwA:15.05hw8F-1jvwA:11.85hw8G-1jvwA:14.3 | 5hw8B-1jvwA:32.475hw8F-1jvwA:32.475hw8G-1jvwA:32.47 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1jvw | MACROPHAGEINFECTIVITYPOTENTIATOR (Trypanosomacruzi) |
PF00254(FKBP_C) | 5 | TYR A 92ASP A 103ILE A 120TYR A 146PHE A 163 | None | 0.77A | 5hw8B-1jvwA:15.05hw8F-1jvwA:11.85hw8G-1jvwA:14.3 | 5hw8B-1jvwA:32.475hw8F-1jvwA:32.475hw8G-1jvwA:32.47 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1jvw | MACROPHAGEINFECTIVITYPOTENTIATOR (Trypanosomacruzi) |
PF00254(FKBP_C) | 6 | TYR A 92VAL A 119ILE A 120TRP A 123TYR A 146PHE A 163 | None | 0.46A | 5hw8B-1jvwA:15.05hw8F-1jvwA:11.85hw8G-1jvwA:14.3 | 5hw8B-1jvwA:32.475hw8F-1jvwA:32.475hw8G-1jvwA:32.47 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1kt1 | FK506-BINDINGPROTEIN FKBP51 (Saimiriboliviensis) |
PF00254(FKBP_C)PF00515(TPR_1)PF13181(TPR_8) | 7 | PHE A 77VAL A 86ILE A 87TRP A 90TYR A 113ILE A 122PHE A 130 | None | 0.94A | 5hw8B-1kt1A:14.45hw8F-1kt1A:11.95hw8G-1kt1A:14.6 | 5hw8B-1kt1A:18.805hw8F-1kt1A:18.805hw8G-1kt1A:18.80 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1kt1 | FK506-BINDINGPROTEIN FKBP51 (Saimiriboliviensis) |
PF00254(FKBP_C)PF00515(TPR_1)PF13181(TPR_8) | 6 | TYR A 57PHE A 77ILE A 87TRP A 90ILE A 122PHE A 130 | None | 0.96A | 5hw8B-1kt1A:14.45hw8F-1kt1A:11.95hw8G-1kt1A:14.6 | 5hw8B-1kt1A:18.805hw8F-1kt1A:18.805hw8G-1kt1A:18.80 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1kt1 | FK506-BINDINGPROTEIN FKBP51 (Saimiriboliviensis) |
PF00254(FKBP_C)PF00515(TPR_1)PF13181(TPR_8) | 7 | TYR A 57PHE A 77VAL A 86ILE A 87TRP A 90ILE A 122PHE A 130 | None | 0.76A | 5hw8B-1kt1A:14.45hw8F-1kt1A:11.95hw8G-1kt1A:14.6 | 5hw8B-1kt1A:18.805hw8F-1kt1A:18.805hw8G-1kt1A:18.80 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1m1s | WR4 (Caenorhabditiselegans) |
PF00635(Motile_Sperm) | 5 | VAL A 146ILE A 121ILE A 101PHE A 190ILE A 200 | None | 1.01A | 5hw8B-1m1sA:undetectable5hw8F-1m1sA:undetectable5hw8G-1m1sA:undetectable | 5hw8B-1m1sA:20.445hw8F-1m1sA:20.445hw8G-1m1sA:20.44 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1n1a | FKBP52 (Homo sapiens) |
PF00254(FKBP_C) | 8 | TYR A 57ASP A 68PHE A 77VAL A 86ILE A 87TRP A 90TYR A 113PHE A 130 | None | 0.61A | 5hw8B-1n1aA:16.55hw8F-1n1aA:13.55hw8G-1n1aA:16.6 | 5hw8B-1n1aA:36.495hw8F-1n1aA:36.495hw8G-1n1aA:36.49 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1pbk | FKBP25 (Homo sapiens) |
PF00254(FKBP_C) | 7 | TYR A 135ASP A 146VAL A 171ILE A 172TRP A 175TYR A 198PHE A 216 | RAP A 225 (-3.9A)RAP A 225 (-3.0A)RAP A 225 (-3.5A)RAP A 225 (-3.9A)RAP A 225 (-3.4A)RAP A 225 (-4.6A)None | 0.41A | 5hw8B-1pbkA:17.95hw8F-1pbkA:15.05hw8G-1pbkA:17.4 | 5hw8B-1pbkA:40.005hw8F-1pbkA:40.005hw8G-1pbkA:40.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1q6h | FKBP-TYPEPEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKPA (Escherichiacoli) |
PF00254(FKBP_C)PF01346(FKBP_N) | 6 | TYR A 146ASP A 157ILE A 174TRP A 177TYR A 200PHE A 216 | None | 0.76A | 5hw8B-1q6hA:15.65hw8F-1q6hA:12.75hw8G-1q6hA:15.2 | 5hw8B-1q6hA:25.635hw8F-1q6hA:25.635hw8G-1q6hA:25.63 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1q6h | FKBP-TYPEPEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKPA (Escherichiacoli) |
PF00254(FKBP_C)PF01346(FKBP_N) | 6 | TYR A 146VAL A 173ILE A 174TRP A 177TYR A 200PHE A 216 | None | 0.50A | 5hw8B-1q6hA:15.65hw8F-1q6hA:12.75hw8G-1q6hA:15.2 | 5hw8B-1q6hA:25.635hw8F-1q6hA:25.635hw8G-1q6hA:25.63 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1r9h | FK506 BINDINGPROTEIN FAMILY (Caenorhabditiselegans) |
PF00254(FKBP_C) | 7 | TYR A 40ASP A 51PHE A 60ILE A 70TRP A 73TYR A 96PHE A 113 | None | 0.68A | 5hw8B-1r9hA:18.15hw8F-1r9hA:14.65hw8G-1r9hA:17.7 | 5hw8B-1r9hA:34.935hw8F-1r9hA:34.935hw8G-1r9hA:34.93 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1r9h | FK506 BINDINGPROTEIN FAMILY (Caenorhabditiselegans) |
PF00254(FKBP_C) | 7 | TYR A 40PHE A 60VAL A 69ILE A 70TRP A 73TYR A 96PHE A 113 | None | 0.35A | 5hw8B-1r9hA:18.15hw8F-1r9hA:14.65hw8G-1r9hA:17.7 | 5hw8B-1r9hA:34.935hw8F-1r9hA:34.935hw8G-1r9hA:34.93 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1u79 | FKBP-TYPEPEPTIDYL-PROLYLCIS-TRANS ISOMERASE3 (Arabidopsisthaliana) |
PF00254(FKBP_C) | 7 | TYR A 37ASP A 48VAL A 66ILE A 67TRP A 70TYR A 99PHE A 121 | None | 0.63A | 5hw8B-1u79A:18.15hw8F-1u79A:15.45hw8G-1u79A:17.4 | 5hw8B-1u79A:40.305hw8F-1u79A:40.305hw8G-1u79A:40.30 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1vim | HYPOTHETICAL PROTEINAF1796 (Archaeoglobusfulgidus) |
PF01380(SIS) | 5 | PHE A 156VAL A 24ILE A 28ILE A 37ILE A 83 | None | 1.00A | 5hw8B-1vimA:undetectable5hw8F-1vimA:undetectable5hw8G-1vimA:undetectable | 5hw8B-1vimA:21.005hw8F-1vimA:21.005hw8G-1vimA:21.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1wba | WINGED BEAN ALBUMIN1 (Psophocarpustetragonolobus) |
PF00197(Kunitz_legume) | 5 | ARG A 155PHE A 118VAL A 94ILE A 146ILE A 21 | None | 1.01A | 5hw8B-1wbaA:undetectable5hw8F-1wbaA:undetectable5hw8G-1wbaA:undetectable | 5hw8B-1wbaA:21.765hw8F-1wbaA:21.765hw8G-1wbaA:21.76 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1yat | FK506 BINDINGPROTEIN (Saccharomycescerevisiae) |
PF00254(FKBP_C) | 8 | TYR A 26ASP A 37PHE A 46VAL A 55ILE A 56TRP A 59TYR A 82PHE A 99 | FK5 A 108 ( 4.0A)FK5 A 108 ( 3.3A)FK5 A 108 ( 4.0A)FK5 A 108 ( 3.4A)FK5 A 108 ( 3.7A)FK5 A 108 ( 3.6A)FK5 A 108 ( 4.7A)None | 0.45A | 5hw8B-1yatA:19.65hw8F-1yatA:15.45hw8G-1yatA:18.7 | 5hw8B-1yatA:55.655hw8F-1yatA:55.655hw8G-1yatA:55.65 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2bm3 | SCAFFOLDING DOCKERINBINDING PROTEIN A (Ruminiclostridiumthermocellum) |
PF00963(Cohesin) | 5 | PHE A 134VAL A 28ILE A 117ILE A 33ILE A 157 | None | 1.02A | 5hw8B-2bm3A:undetectable5hw8F-2bm3A:undetectable5hw8G-2bm3A:undetectable | 5hw8B-2bm3A:26.045hw8F-2bm3A:26.045hw8G-2bm3A:26.04 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2c4n | PROTEIN NAGD (Escherichiacoli) |
PF13242(Hydrolase_like)PF13344(Hydrolase_6) | 5 | VAL A 249ILE A 250ILE A 7PHE A 27ILE A 207 | None | 0.99A | 5hw8B-2c4nA:undetectable5hw8F-2c4nA:undetectable5hw8G-2c4nA:undetectable | 5hw8B-2c4nA:20.315hw8F-2c4nA:20.315hw8G-2c4nA:20.31 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2hf7 | CLASS B ACIDPHOSPHATASE (Escherichiacoli) |
PF03767(Acid_phosphat_B) | 5 | ASP A 171VAL A 140ILE A 141ILE A 161ILE A 185 | MG A 700 ( 4.5A)NoneNoneNoneNone | 1.11A | 5hw8B-2hf7A:undetectable5hw8F-2hf7A:undetectable5hw8G-2hf7A:undetectable | 5hw8B-2hf7A:23.505hw8F-2hf7A:23.505hw8G-2hf7A:23.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2lpv | FKBP-TYPEPEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Aedes aegypti) |
PF00254(FKBP_C) | 5 | TYR A 27PHE A 47VAL A 56ILE A 57TRP A 60 | None | 0.85A | 5hw8B-2lpvA:16.25hw8F-2lpvA:13.05hw8G-2lpvA:15.7 | 5hw8B-2lpvA:46.675hw8F-2lpvA:46.675hw8G-2lpvA:46.67 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2pbc | FK506-BINDINGPROTEIN 2 (Homo sapiens) |
PF00254(FKBP_C) | 8 | TYR A 56ASP A 67PHE A 76VAL A 85ILE A 86TRP A 89TYR A 112PHE A 129 | PEG A 201 (-4.4A)NonePEG A 201 ( 3.9A)PEG A 201 (-3.6A)PEG A 201 (-3.8A)PEG A 201 (-3.7A)NoneNone | 0.62A | 5hw8B-2pbcA:15.35hw8F-2pbcA:12.85hw8G-2pbcA:14.5 | 5hw8B-2pbcA:44.145hw8F-2pbcA:44.145hw8G-2pbcA:44.14 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2pbc | FK506-BINDINGPROTEIN 2 (Homo sapiens) |
PF00254(FKBP_C) | 5 | TYR A 56ASP A 67PHE A 76VAL A 85ILE A 121 | PEG A 201 (-4.4A)NonePEG A 201 ( 3.9A)PEG A 201 (-3.6A)None | 1.04A | 5hw8B-2pbcA:15.35hw8F-2pbcA:12.85hw8G-2pbcA:14.5 | 5hw8B-2pbcA:44.145hw8F-2pbcA:44.145hw8G-2pbcA:44.14 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2pcn | S-ADENOSYLMETHIONINE:2-DEMETHYLMENAQUINONE METHYLTRANSFERASE (Geobacilluskaustophilus) |
PF03737(RraA-like) | 5 | VAL A 62ILE A 96ILE A 102PHE A 32ILE A 81 | None | 1.12A | 5hw8B-2pcnA:undetectable5hw8F-2pcnA:undetectable5hw8G-2pcnA:undetectable | 5hw8B-2pcnA:22.705hw8F-2pcnA:22.705hw8G-2pcnA:22.70 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2pd2 | HYPOTHETICAL PROTEINST0148 (Sulfurisphaeratokodaii) |
PF02635(DrsE) | 5 | ARG A 51PHE A 10ILE A 82ILE A 85ILE A 7 | None | 1.08A | 5hw8B-2pd2A:undetectable5hw8F-2pd2A:undetectable5hw8G-2pd2A:undetectable | 5hw8B-2pd2A:19.055hw8F-2pd2A:19.055hw8G-2pd2A:19.05 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2q0x | UNCHARACTERIZEDPROTEIN (Trypanosomabrucei) |
PF08538(DUF1749) | 5 | ASP A 95ILE A 28TYR A 20ILE A 100ILE A 135 | None | 0.99A | 5hw8B-2q0xA:undetectable5hw8F-2q0xA:undetectable5hw8G-2q0xA:undetectable | 5hw8B-2q0xA:17.345hw8F-2q0xA:17.345hw8G-2q0xA:17.34 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) |
PF00254(FKBP_C)PF01346(FKBP_N) | 6 | TYR A 55ASP A 66VAL A 82ILE A 83TRP A 86PHE A 126 | RAP A 138 (-2.6A)RAP A 138 (-2.7A)RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A)RAP A 138 ( 4.7A) | 0.79A | 5hw8B-2vcdA:13.25hw8F-2vcdA:10.55hw8G-2vcdA:13.1 | 5hw8B-2vcdA:34.905hw8F-2vcdA:34.905hw8G-2vcdA:34.90 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) |
PF00254(FKBP_C)PF01346(FKBP_N) | 6 | TYR A 55VAL A 82ILE A 83TRP A 86TYR A 109PHE A 126 | RAP A 138 (-2.6A)RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A)RAP A 138 (-3.8A)RAP A 138 ( 4.7A) | 0.85A | 5hw8B-2vcdA:13.25hw8F-2vcdA:10.55hw8G-2vcdA:13.1 | 5hw8B-2vcdA:34.905hw8F-2vcdA:34.905hw8G-2vcdA:34.90 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2vn1 | 70 KDAPEPTIDYLPROLYLISOMERASE (Plasmodiumfalciparum) |
PF00254(FKBP_C) | 8 | TYR A 44ASP A 56PHE A 65VAL A 74ILE A 75TRP A 78TYR A 101PHE A 118 | FK5 A 501 (-4.1A)FK5 A 501 (-3.4A)FK5 A 501 (-4.1A)FK5 A 501 (-3.5A)FK5 A 501 (-4.3A)FK5 A 501 (-3.3A)FK5 A 501 (-4.7A)FK5 A 501 (-4.8A) | 0.45A | 5hw8B-2vn1A:17.65hw8F-2vn1A:14.55hw8G-2vn1A:17.4 | 5hw8B-2vn1A:33.095hw8F-2vn1A:33.095hw8G-2vn1A:33.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2y78 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Burkholderiapseudomallei) |
PF00254(FKBP_C) | 5 | TYR A 33ASP A 44PHE A 53ILE A 63TYR A 89 | None | 0.76A | 5hw8B-2y78A:17.25hw8F-2y78A:14.25hw8G-2y78A:16.5 | 5hw8B-2y78A:47.905hw8F-2y78A:47.905hw8G-2y78A:47.90 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2y78 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Burkholderiapseudomallei) |
PF00254(FKBP_C) | 7 | TYR A 33PHE A 53VAL A 62ILE A 63TRP A 66TYR A 89PHE A 106 | None | 0.45A | 5hw8B-2y78A:17.25hw8F-2y78A:14.25hw8G-2y78A:16.5 | 5hw8B-2y78A:47.905hw8F-2y78A:47.905hw8G-2y78A:47.90 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2zu6 | PROGRAMMED CELLDEATH PROTEIN 4 (Homo sapiens) |
PF02847(MA3) | 5 | PHE B 380ILE B 368TYR B 405ILE B 439ILE B 438 | None | 1.10A | 5hw8B-2zu6B:undetectable5hw8F-2zu6B:undetectable5hw8G-2zu6B:undetectable | 5hw8B-2zu6B:18.945hw8F-2zu6B:18.945hw8G-2zu6B:18.94 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3hkz | DNA-DIRECTED RNAPOLYMERASE, SUBUNITG (RPOG) (Sulfolobussolfataricus) |
PF16992(RNA_pol_RpbG) | 5 | TYR G 92PHE G 40VAL G 57ILE G 59ILE G 46 | None | 1.12A | 5hw8B-3hkzG:undetectable5hw8F-3hkzG:undetectable5hw8G-3hkzG:undetectable | 5hw8B-3hkzG:20.865hw8F-3hkzG:20.865hw8G-3hkzG:20.86 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ilr | HEPARIN LYASE I (Bacteroidesthetaiotaomicron) |
PF14099(Polysacc_lyase) | 5 | PHE A 231VAL A 297ILE A 299TRP A 150ILE A 340 | None | 0.99A | 5hw8B-3ilrA:undetectable5hw8F-3ilrA:undetectable5hw8G-3ilrA:undetectable | 5hw8B-3ilrA:14.715hw8F-3ilrA:14.715hw8G-3ilrA:14.71 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3nkg | UNCHARACTERIZEDPROTEINGEBA250068378 (Sulfurospirillumdeleyianum) |
no annotation | 5 | ASP A 161PHE A 35ILE A 132ILE A 146ILE A 6 | None | 1.13A | 5hw8B-3nkgA:undetectable5hw8F-3nkgA:undetectable5hw8G-3nkgA:undetectable | 5hw8B-3nkgA:24.045hw8F-3nkgA:24.045hw8G-3nkgA:24.04 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3o5d | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP5 (Homo sapiens) |
PF00254(FKBP_C) | 6 | TYR A 57ASP A 68PHE A 77ILE A 87TYR A 113PHE A 130 | None | 0.75A | 5hw8B-3o5dA:17.15hw8F-3o5dA:14.25hw8G-3o5dA:16.6 | 5hw8B-3o5dA:27.205hw8F-3o5dA:27.205hw8G-3o5dA:27.20 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3o5d | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP5 (Homo sapiens) |
PF00254(FKBP_C) | 7 | TYR A 57PHE A 77VAL A 86ILE A 87TRP A 90TYR A 113PHE A 130 | None | 0.61A | 5hw8B-3o5dA:17.15hw8F-3o5dA:14.25hw8G-3o5dA:16.6 | 5hw8B-3o5dA:27.205hw8F-3o5dA:27.205hw8G-3o5dA:27.20 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3o5e | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP5 (Homo sapiens) |
PF00254(FKBP_C) | 6 | TYR A 57ASP A 68PHE A 77ILE A 87TYR A 113PHE A 130 | None | 0.72A | 5hw8B-3o5eA:17.15hw8F-3o5eA:14.15hw8G-3o5eA:16.9 | 5hw8B-3o5eA:39.725hw8F-3o5eA:39.725hw8G-3o5eA:39.72 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3o5e | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP5 (Homo sapiens) |
PF00254(FKBP_C) | 7 | TYR A 57PHE A 77VAL A 86ILE A 87TRP A 90TYR A 113PHE A 130 | None | 0.71A | 5hw8B-3o5eA:17.15hw8F-3o5eA:14.15hw8G-3o5eA:16.9 | 5hw8B-3o5eA:39.725hw8F-3o5eA:39.725hw8G-3o5eA:39.72 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3o5e | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP5 (Homo sapiens) |
PF00254(FKBP_C) | 6 | TYR A 57PHE A 77VAL A 86ILE A 87TYR A 113ILE A 122 | None | 1.44A | 5hw8B-3o5eA:17.15hw8F-3o5eA:14.15hw8G-3o5eA:16.9 | 5hw8B-3o5eA:39.725hw8F-3o5eA:39.725hw8G-3o5eA:39.72 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3pa7 | 70 KDAPEPTIDYLPROLYLISOMERASE, PUTATIVE (Plasmodiumvivax) |
PF00254(FKBP_C) | 6 | TYR A 43ASP A 55PHE A 64ILE A 74TYR A 100PHE A 117 | None | 0.73A | 5hw8B-3pa7A:17.25hw8F-3pa7A:14.15hw8G-3pa7A:17.0 | 5hw8B-3pa7A:36.435hw8F-3pa7A:36.435hw8G-3pa7A:36.43 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3pa7 | 70 KDAPEPTIDYLPROLYLISOMERASE, PUTATIVE (Plasmodiumvivax) |
PF00254(FKBP_C) | 7 | TYR A 43PHE A 64VAL A 73ILE A 74TRP A 77TYR A 100PHE A 117 | None | 0.39A | 5hw8B-3pa7A:17.25hw8F-3pa7A:14.15hw8G-3pa7A:17.0 | 5hw8B-3pa7A:36.435hw8F-3pa7A:36.435hw8G-3pa7A:36.43 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ukf | UDP-GALACTOPYRANOSEMUTASE (Aspergillusfumigatus) |
PF13450(NAD_binding_8) | 5 | ARG A 306TYR A 58PHE A 56ILE A 310ILE A 407 | None | 1.10A | 5hw8B-3ukfA:undetectable5hw8F-3ukfA:undetectable5hw8G-3ukfA:undetectable | 5hw8B-3ukfA:13.565hw8F-3ukfA:13.565hw8G-3ukfA:13.56 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3zu4 | PUTATIVE REDUCTASEYPO4104/Y4119/YP_4011 (Yersinia pestis) |
PF07055(Eno-Rase_FAD_bd)PF12241(Enoyl_reductase)PF12242(Eno-Rase_NADH_b) | 5 | PHE A 223VAL A 46ILE A 47ILE A 205ILE A 254 | None | 1.02A | 5hw8B-3zu4A:undetectable5hw8F-3zu4A:undetectable5hw8G-3zu4A:undetectable | 5hw8B-3zu4A:14.715hw8F-3zu4A:14.715hw8G-3zu4A:14.71 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4bf8 | FPR4 (Saccharomycescerevisiae) |
PF00254(FKBP_C) | 5 | ASP A 324VAL A 341ILE A 342TYR A 368PHE A 384 | None | 0.89A | 5hw8B-4bf8A:15.25hw8F-4bf8A:13.05hw8G-4bf8A:14.9 | 5hw8B-4bf8A:37.125hw8F-4bf8A:37.125hw8G-4bf8A:37.12 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4bf8 | FPR4 (Saccharomycescerevisiae) |
PF00254(FKBP_C) | 6 | TYR A 313ASP A 324PHE A 332VAL A 341ILE A 342PHE A 384 | None | 0.88A | 5hw8B-4bf8A:15.25hw8F-4bf8A:13.05hw8G-4bf8A:14.9 | 5hw8B-4bf8A:37.125hw8F-4bf8A:37.125hw8G-4bf8A:37.12 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4bf8 | FPR4 (Saccharomycescerevisiae) |
PF00254(FKBP_C) | 6 | TYR A 313PHE A 332VAL A 341ILE A 342TRP A 345PHE A 384 | None | 0.77A | 5hw8B-4bf8A:15.25hw8F-4bf8A:13.05hw8G-4bf8A:14.9 | 5hw8B-4bf8A:37.125hw8F-4bf8A:37.125hw8G-4bf8A:37.12 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4bf8 | FPR4 (Saccharomycescerevisiae) |
PF00254(FKBP_C) | 5 | VAL A 341ILE A 342TRP A 345TYR A 368PHE A 384 | None | 0.71A | 5hw8B-4bf8A:15.25hw8F-4bf8A:13.05hw8G-4bf8A:14.9 | 5hw8B-4bf8A:37.125hw8F-4bf8A:37.125hw8G-4bf8A:37.12 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4dz3 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Burkholderiapseudomallei) |
PF00254(FKBP_C) | 8 | TYR A 33ASP A 44PHE A 53VAL A 62ILE A 63TRP A 66TYR A 89PHE A 106 | FK5 A 201 ( 3.9A)FK5 A 201 (-3.5A)FK5 A 201 (-4.1A)FK5 A 201 ( 3.6A)FK5 A 201 (-3.8A)FK5 A 201 (-3.4A)FK5 A 201 (-4.7A)FK5 A 201 (-4.8A) | 0.42A | 5hw8B-4dz3A:18.15hw8F-4dz3A:15.15hw8G-4dz3A:17.5 | 5hw8B-4dz3A:47.905hw8F-4dz3A:47.905hw8G-4dz3A:47.90 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4ga4 | PUTATIVE THYMIDINEPHOSPHORYLASE (Thermococcuskodakarensis) |
PF00591(Glycos_transf_3)PF02885(Glycos_trans_3N)PF07831(PYNP_C) | 5 | ASP A 119VAL A 88ILE A 91ILE A 112ILE A 245 | None | 1.09A | 5hw8B-4ga4A:undetectable5hw8F-4ga4A:undetectable5hw8G-4ga4A:undetectable | 5hw8B-4ga4A:15.465hw8F-4ga4A:15.465hw8G-4ga4A:15.46 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4ga6 | PUTATIVE THYMIDINEPHOSPHORYLASE (Thermococcuskodakarensis) |
PF00591(Glycos_transf_3)PF02885(Glycos_trans_3N)PF07831(PYNP_C) | 5 | ASP A 119VAL A 88ILE A 91ILE A 112ILE A 245 | None | 1.11A | 5hw8B-4ga6A:undetectable5hw8F-4ga6A:undetectable5hw8G-4ga6A:undetectable | 5hw8B-4ga6A:13.045hw8F-4ga6A:13.045hw8G-4ga6A:13.04 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4h63 | MEDIATOR OF RNAPOLYMERASE IITRANSCRIPTIONSUBUNIT 11MEDIATOR OF RNAPOLYMERASE IITRANSCRIPTIONSUBUNIT 22 (Schizosaccharomycespombe) |
PF06179(Med22)no annotation | 5 | ARG V 31VAL V 67ILE V 28ILE V 35PHE K 61 | None | 1.03A | 5hw8B-4h63V:undetectable5hw8F-4h63V:undetectable5hw8G-4h63V:undetectable | 5hw8B-4h63V:21.135hw8F-4h63V:21.135hw8G-4h63V:21.13 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4ipe | TNFRECEPTOR-ASSOCIATEDPROTEIN 1 (Danio rerio) |
PF00183(HSP90)PF13589(HATPase_c_3) | 5 | VAL A 288ILE A 300ILE A 158PHE A 169ILE A 213 | None | 1.05A | 5hw8B-4ipeA:undetectable5hw8F-4ipeA:undetectable5hw8G-4ipeA:undetectable | 5hw8B-4ipeA:11.765hw8F-4ipeA:11.765hw8G-4ipeA:11.76 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4iqc | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP1B (Homo sapiens) |
PF00254(FKBP_C) | 5 | TYR A 26ASP A 37ILE A 56TYR A 82PHE A 99 | None | 0.77A | 5hw8B-4iqcA:18.75hw8F-4iqcA:14.95hw8G-4iqcA:17.9 | 5hw8B-4iqcA:46.725hw8F-4iqcA:46.725hw8G-4iqcA:46.72 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4iqc | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP1B (Homo sapiens) |
PF00254(FKBP_C) | 6 | TYR A 26PHE A 46VAL A 55ILE A 56TYR A 82PHE A 99 | None | 0.76A | 5hw8B-4iqcA:18.75hw8F-4iqcA:14.95hw8G-4iqcA:17.9 | 5hw8B-4iqcA:46.725hw8F-4iqcA:46.725hw8G-4iqcA:46.72 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homo sapiens) |
PF00254(FKBP_C) | 7 | TYR A 57ASP A 68PHE A 77VAL A 86ILE A 87TRP A 90PHE A 130 | NoneNoneNoneDMS A 304 (-3.5A)DMS A 304 (-3.8A)DMS A 304 ( 4.0A)DMS A 304 (-4.3A) | 0.61A | 5hw8B-4lawA:17.75hw8F-4lawA:14.95hw8G-4lawA:17.3 | 5hw8B-4lawA:27.185hw8F-4lawA:27.185hw8G-4lawA:27.18 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homo sapiens) |
PF00254(FKBP_C) | 5 | TYR A 57ASP A 68PHE A 77VAL A 86ILE A 122 | NoneNoneNoneDMS A 304 (-3.5A)None | 1.12A | 5hw8B-4lawA:17.75hw8F-4lawA:14.95hw8G-4lawA:17.3 | 5hw8B-4lawA:27.185hw8F-4lawA:27.185hw8G-4lawA:27.18 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homo sapiens) |
PF00254(FKBP_C) | 7 | TYR A 57PHE A 77VAL A 86ILE A 87TRP A 90TYR A 113PHE A 130 | NoneNoneDMS A 304 (-3.5A)DMS A 304 (-3.8A)DMS A 304 ( 4.0A)NoneDMS A 304 (-4.3A) | 0.44A | 5hw8B-4lawA:17.75hw8F-4lawA:14.95hw8G-4lawA:17.3 | 5hw8B-4lawA:27.185hw8F-4lawA:27.185hw8G-4lawA:27.18 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homo sapiens) |
PF00254(FKBP_C) | 6 | TYR A 57PHE A 77VAL A 86ILE A 87TYR A 113ILE A 122 | NoneNoneDMS A 304 (-3.5A)DMS A 304 (-3.8A)NoneNone | 1.43A | 5hw8B-4lawA:17.75hw8F-4lawA:14.95hw8G-4lawA:17.3 | 5hw8B-4lawA:27.185hw8F-4lawA:27.185hw8G-4lawA:27.18 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4mki | ENERGY-COUPLINGFACTOR TRANSPORTERATP-BINDING PROTEINECFA2 (Caldanaerobactersubterraneus) |
no annotation | 5 | ILE B 3ILE B 166ILE B 50PHE B 28ILE B 207 | None | 1.11A | 5hw8B-4mkiB:undetectable5hw8F-4mkiB:undetectable5hw8G-4mkiB:undetectable | 5hw8B-4mkiB:20.765hw8F-4mkiB:20.765hw8G-4mkiB:20.76 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4nnr | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP2 (Homo sapiens) |
PF00254(FKBP_C) | 8 | TYR A 56ASP A 67PHE A 76VAL A 85ILE A 86TRP A 89TYR A 112PHE A 129 | FK5 A 201 (-4.1A)FK5 A 201 (-3.4A)FK5 A 201 (-4.0A)FK5 A 201 (-3.4A)FK5 A 201 (-3.8A)FK5 A 201 (-3.5A)FK5 A 201 (-4.5A)FK5 A 201 (-4.9A) | 0.40A | 5hw8B-4nnrA:15.45hw8F-4nnrA:13.15hw8G-4nnrA:15.0 | 5hw8B-4nnrA:36.005hw8F-4nnrA:36.005hw8G-4nnrA:36.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4odm | PEPTIDYL-PROLYLCIS-TRANS ISOMERASESLYD (Thermusthermophilus) |
PF00254(FKBP_C) | 5 | TYR A 13ASP A 23ILE A 37TYR A 63PHE A 128 | None | 0.48A | 5hw8B-4odmA:10.95hw8F-4odmA:9.65hw8G-4odmA:11.1 | 5hw8B-4odmA:19.485hw8F-4odmA:19.485hw8G-4odmA:19.48 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4odr | PEPTIDYL-PROLYLCIS-TRANS ISOMERASESLYD,PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP1A CHIMERA (Homo sapiens;Thermusthermophilus) |
PF00254(FKBP_C) | 6 | TYR A 13ASP A 23ILE A 37TYR A 63ILE A 71PHE A 80 | FK5 A 201 ( 3.6A)FK5 A 201 (-3.6A)FK5 A 201 (-3.9A)FK5 A 201 (-4.4A)FK5 A 201 ( 4.1A)FK5 A 201 ( 4.8A) | 0.52A | 5hw8B-4odrA:12.55hw8F-4odrA:11.45hw8G-4odrA:12.6 | 5hw8B-4odrA:26.215hw8F-4odrA:26.215hw8G-4odrA:26.21 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4r0x | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP5 (Homo sapiens) |
PF00254(FKBP_C) | 6 | TYR A 57ASP A 68PHE A 77ILE A 87TYR A 113PHE A 130 | None | 0.79A | 5hw8B-4r0xA:17.75hw8F-4r0xA:14.45hw8G-4r0xA:17.5 | 5hw8B-4r0xA:40.005hw8F-4r0xA:40.005hw8G-4r0xA:40.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4r0x | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP5 (Homo sapiens) |
PF00254(FKBP_C) | 7 | TYR A 57PHE A 77VAL A 86ILE A 87TRP A 90TYR A 113PHE A 130 | None | 0.55A | 5hw8B-4r0xA:17.75hw8F-4r0xA:14.45hw8G-4r0xA:17.5 | 5hw8B-4r0xA:40.005hw8F-4r0xA:40.005hw8G-4r0xA:40.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4rfa | LMO0740 PROTEIN (Listeriamonocytogenes) |
no annotation | 5 | VAL A 53ILE A 90ILE A 46PHE A 35ILE A 125 | None | 1.11A | 5hw8B-4rfaA:undetectable5hw8F-4rfaA:undetectable5hw8G-4rfaA:undetectable | 5hw8B-4rfaA:17.625hw8F-4rfaA:17.625hw8G-4rfaA:17.62 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4ylr | TUBULINPOLYGLUTAMYLASETTLL7 (Homo sapiens) |
PF03133(TTL) | 6 | PHE A 127VAL A 305ILE A 304ILE A 218ILE A 457ILE A 337 | None | 1.21A | 5hw8B-4ylrA:undetectable5hw8F-4ylrA:undetectable5hw8G-4ylrA:undetectable | 5hw8B-4ylrA:16.115hw8F-4ylrA:16.115hw8G-4ylrA:16.11 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5b8i | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Coccidioidesimmitis) |
PF00254(FKBP_C) | 8 | TYR C 36ASP C 56PHE C 64VAL C 73ILE C 74TRP C 77TYR C 100PHE C 117 | FK5 C 201 (-4.1A)FK5 C 201 ( 3.8A)FK5 C 201 (-3.8A)FK5 C 201 (-3.5A)FK5 C 201 (-3.8A)FK5 C 201 (-3.4A)FK5 C 201 (-4.5A)FK5 C 201 (-4.7A) | 0.44A | 5hw8B-5b8iC:19.15hw8F-5b8iC:15.25hw8G-5b8iC:18.1 | 5hw8B-5b8iC:37.865hw8F-5b8iC:37.865hw8G-5b8iC:37.86 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5dp2 | CURF (Lyngbyamajuscula) |
PF08240(ADH_N)PF13602(ADH_zinc_N_2) | 5 | VAL A 222ILE A 241ILE A 235PHE A 209ILE A 251 | NoneNoneNoneNoneNAP A 401 (-3.8A) | 1.04A | 5hw8B-5dp2A:undetectable5hw8F-5dp2A:undetectable5hw8G-5dp2A:undetectable | 5hw8B-5dp2A:18.715hw8F-5dp2A:18.715hw8G-5dp2A:18.71 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5hgc | SERPIN (Taeniopygiaguttata) |
PF00079(Serpin) | 5 | ARG A 246ILE A 277ILE A 379PHE A 40ILE A 393 | HCY A 501 (-3.0A)HCY A 501 ( 4.2A)NoneNoneNone | 1.02A | 5hw8B-5hgcA:undetectable5hw8F-5hgcA:undetectable5hw8G-5hgcA:undetectable | 5hw8B-5hgcA:17.075hw8F-5hgcA:17.075hw8G-5hgcA:17.07 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5i7p | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP1A,FKBP-TYPEPEPTIDYL-PROLYLCIS-TRANS ISOMERASESLYD,PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP1A (Escherichiacoli;Homo sapiens) |
PF00254(FKBP_C) | 7 | TYR A 26ASP A 37PHE A 46ILE A 56TRP A 59TYR A 82PHE A 146 | None | 0.53A | 5hw8B-5i7pA:17.15hw8F-5i7pA:13.15hw8G-5i7pA:16.5 | 5hw8B-5i7pA:32.285hw8F-5i7pA:32.285hw8G-5i7pA:32.28 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5i7p | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP1A,FKBP-TYPEPEPTIDYL-PROLYLCIS-TRANS ISOMERASESLYD,PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP1A (Escherichiacoli;Homo sapiens) |
PF00254(FKBP_C) | 7 | TYR A 26PHE A 46VAL A 55ILE A 56TRP A 59TYR A 82PHE A 146 | None | 0.42A | 5hw8B-5i7pA:17.15hw8F-5i7pA:13.15hw8G-5i7pA:16.5 | 5hw8B-5i7pA:32.285hw8F-5i7pA:32.285hw8G-5i7pA:32.28 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5i7q | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP1A,FKBP-TYPE 16KDA PEPTIDYL-PROLYLCIS-TRANSISOMERASE,PEPTIDYL-PROLYL CIS-TRANSISOMERASE FKBP1A (Escherichiacoli;Homo sapiens) |
PF00254(FKBP_C) | 8 | TYR A 26ASP A 37PHE A 46VAL A 55ILE A 56TRP A 59TYR A 82PHE A 147 | None | 0.60A | 5hw8B-5i7qA:17.45hw8F-5i7qA:13.45hw8G-5i7qA:16.8 | 5hw8B-5i7qA:32.945hw8F-5i7qA:32.945hw8G-5i7qA:32.94 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5i98 | FK506-BINDINGPROTEIN 1 (Candidaalbicans) |
PF00254(FKBP_C) | 10 | TYR A 30ASP A 41PHE A 50VAL A 59ILE A 60TRP A 63TYR A 97ILE A 102ILE A 105PHE A 114 | None | 0.68A | 5hw8B-5i98A:24.75hw8F-5i98A:18.95hw8G-5i98A:23.5 | 5hw8B-5i98A:100.005hw8F-5i98A:100.005hw8G-5i98A:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5i98 | FK506-BINDINGPROTEIN 1 (Candidaalbicans) |
PF00254(FKBP_C) | 6 | TYR A 30PHE A 50VAL A 59TRP A 63ILE A 102PHE A 114 | None | 1.02A | 5hw8B-5i98A:24.75hw8F-5i98A:18.95hw8G-5i98A:23.5 | 5hw8B-5i98A:100.005hw8F-5i98A:100.005hw8G-5i98A:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5j6e | FK506-BINDINGPROTEIN 1A (Aspergillusfumigatus) |
PF00254(FKBP_C) | 7 | TYR A 27ASP A 38PHE A 47VAL A 56ILE A 57TYR A 83PHE A 100 | None | 0.63A | 5hw8B-5j6eA:20.05hw8F-5j6eA:15.25hw8G-5j6eA:18.4 | 5hw8B-5j6eA:46.725hw8F-5j6eA:46.725hw8G-5j6eA:46.72 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5j6e | FK506-BINDINGPROTEIN 1A (Aspergillusfumigatus) |
PF00254(FKBP_C) | 7 | TYR A 27PHE A 47VAL A 56ILE A 57TRP A 60TYR A 83PHE A 100 | None | 0.48A | 5hw8B-5j6eA:20.05hw8F-5j6eA:15.25hw8G-5j6eA:18.4 | 5hw8B-5j6eA:46.725hw8F-5j6eA:46.725hw8G-5j6eA:46.72 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5m0y | CELLULOSOMEANCHORING PROTEINCOHESIN REGION (Ruminiclostridiumthermocellum) |
PF00963(Cohesin) | 5 | PHE A 146VAL A 40ILE A 129ILE A 45ILE A 169 | None | 1.02A | 5hw8B-5m0yA:undetectable5hw8F-5m0yA:undetectable5hw8G-5m0yA:undetectable | 5hw8B-5m0yA:23.815hw8F-5m0yA:23.815hw8G-5m0yA:23.81 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5n81 | TYROCIDINE SYNTHASE1 (Brevibacillusparabrevis) |
no annotation | 5 | VAL A 101ILE A 104TYR A 114ILE A 186PHE A 240 | None | 1.04A | 5hw8B-5n81A:undetectable5hw8F-5n81A:undetectable5hw8G-5n81A:undetectable | 5hw8B-5n81A:14.295hw8F-5n81A:14.295hw8G-5n81A:14.29 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5n94 | CG9323, ISOFORM A (Drosophilamelanogaster) |
no annotation | 5 | ILE A 218TYR A 253ILE A 251ILE A 205ILE A 162 | None | 0.87A | 5hw8B-5n94A:undetectable5hw8F-5n94A:undetectable5hw8G-5n94A:undetectable | 5hw8B-5n94A:18.855hw8F-5n94A:18.855hw8G-5n94A:18.85 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5o6u | UNCHARACTERIZEDPROTEIN (Shewanellaputrefaciens) |
no annotation | 5 | TYR F 81VAL F 301ILE F 299ILE F 334PHE F 82 | None | 1.10A | 5hw8B-5o6uF:undetectable5hw8F-5o6uF:undetectable5hw8G-5o6uF:undetectable | 5hw8B-5o6uF:16.945hw8F-5o6uF:16.945hw8G-5o6uF:16.94 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5tth | C-TERMINALSPYCATCHER FUSION OFWILDTYPE ZEBRAFISHTNFRECEPTOR-ASSOCIATEDPROTEIN 1 (Danio rerio;Streptococcuspyogenes) |
PF00183(HSP90)PF13589(HATPase_c_3) | 5 | VAL A 288ILE A 300ILE A 158PHE A 169ILE A 213 | None | 1.06A | 5hw8B-5tthA:undetectable5hw8F-5tthA:undetectable5hw8G-5tthA:undetectable | 5hw8B-5tthA:10.455hw8F-5tthA:10.455hw8G-5tthA:10.45 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5v38 | HCHA (Clostridiumbotulinum) |
PF07951(Toxin_R_bind_C)PF07953(Toxin_R_bind_N) | 5 | TYR A 942ILE A1003ILE A1007ILE A 937ILE A 976 | None | 1.12A | 5hw8B-5v38A:undetectable5hw8F-5v38A:undetectable5hw8G-5v38A:undetectable | 5hw8B-5v38A:14.255hw8F-5v38A:14.255hw8G-5v38A:14.25 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5v8t | UBIQUITIN-LIKEPROTEINSMT3,PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Burkholderiapseudomallei;Saccharomycescerevisiae) |
no annotation | 8 | TYR A 33ASP A 44PHE A 53VAL A 62ILE A 63TRP A 66TYR A 89PHE A 106 | 8ZV A 201 (-3.8A)8ZV A 201 (-3.9A)8ZV A 201 (-3.9A)8ZV A 201 (-3.6A)8ZV A 201 (-4.0A)8ZV A 201 (-3.3A)8ZV A 201 (-4.6A)8ZV A 201 (-4.6A) | 0.39A | 5hw8B-5v8tA:18.05hw8F-5v8tA:14.85hw8G-5v8tA:17.4 | 5hw8B-5v8tA:19.335hw8F-5v8tA:19.335hw8G-5v8tA:19.33 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5wea | PROTEIN ARGONAUTE-2 (Homo sapiens) |
no annotation | 5 | VAL A 113ILE A 132ILE A 61ILE A 74PHE A 87 | None | 0.85A | 5hw8B-5weaA:undetectable5hw8F-5weaA:undetectable5hw8G-5weaA:undetectable | 5hw8B-5weaA:21.145hw8F-5weaA:21.145hw8G-5weaA:21.14 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5x00 | NUCLEOSIDEDIPHOSPHATE KINASE (Vibrio cholerae) |
no annotation | 5 | PHE A 133ILE A 34TYR A 24ILE A 20ILE A 10 | None | 1.13A | 5hw8B-5x00A:undetectable5hw8F-5x00A:undetectable5hw8G-5x00A:undetectable | 5hw8B-5x00A:20.875hw8F-5x00A:20.875hw8G-5x00A:20.87 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5xb0 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Pseudomonassyringae groupgenomosp. 3) |
PF00254(FKBP_C) | 7 | TYR A 147ASP A 158VAL A 171ILE A 172TRP A 175TYR A 198PHE A 215 | TLA A 301 ( 4.4A)TLA A 301 (-3.7A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)NoneNone | 0.76A | 5hw8B-5xb0A:15.15hw8F-5xb0A:12.25hw8G-5xb0A:15.2 | 5hw8B-5xb0A:27.945hw8F-5xb0A:27.945hw8G-5xb0A:27.94 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5xb0 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Pseudomonassyringae groupgenomosp. 3) |
PF00254(FKBP_C) | 6 | TYR A 147PHE A 166ILE A 172TRP A 175TYR A 198PHE A 215 | TLA A 301 ( 4.4A)TLA A 301 ( 4.6A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)NoneNone | 1.03A | 5hw8B-5xb0A:15.15hw8F-5xb0A:12.25hw8G-5xb0A:15.2 | 5hw8B-5xb0A:27.945hw8F-5xb0A:27.945hw8G-5xb0A:27.94 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6b4p | PEPTIDYLPROLYLISOMERASE (Naegleriafowleri) |
no annotation | 8 | TYR A 38ASP A 49PHE A 58VAL A 67ILE A 68TYR A 94ILE A 99PHE A 111 | None | 0.55A | 5hw8B-6b4pA:17.95hw8F-6b4pA:14.45hw8G-6b4pA:17.2 | 5hw8B-6b4pA:37.685hw8F-6b4pA:37.685hw8G-6b4pA:37.68 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6b4p | PEPTIDYLPROLYLISOMERASE (Naegleriafowleri) |
no annotation | 5 | TYR A 38PHE A 58TRP A 71ILE A 99PHE A 111 | None | 1.00A | 5hw8B-6b4pA:17.95hw8F-6b4pA:14.45hw8G-6b4pA:17.2 | 5hw8B-6b4pA:37.685hw8F-6b4pA:37.685hw8G-6b4pA:37.68 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6b4p | PEPTIDYLPROLYLISOMERASE (Naegleriafowleri) |
no annotation | 8 | TYR A 38PHE A 58VAL A 67ILE A 68TRP A 71TYR A 94ILE A 99PHE A 111 | None | 0.60A | 5hw8B-6b4pA:17.95hw8F-6b4pA:14.45hw8G-6b4pA:17.2 | 5hw8B-6b4pA:37.685hw8F-6b4pA:37.685hw8G-6b4pA:37.68 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6ck9 | GP120 OF ENVELOPEGLYCOPROTEIN GP160 (Humanimmunodeficiencyvirus 1) |
no annotation | 5 | PHE G 159ILE G 181ILE G 423ILE G 201ILE G 309 | None | 1.03A | 5hw8B-6ck9G:undetectable5hw8F-6ck9G:undetectable5hw8G-6ck9G:undetectable | 5hw8B-6ck9G:16.395hw8F-6ck9G:16.395hw8G-6ck9G:16.39 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6d14 | TNFRECEPTOR-ASSOCIATEDPROTEIN 1 (Danio rerio) |
no annotation | 5 | VAL A 288ILE A 300ILE A 158PHE A 169ILE A 213 | None | 1.03A | 5hw8B-6d14A:undetectable5hw8F-6d14A:undetectable5hw8G-6d14A:undetectable | 5hw8B-6d14A:19.515hw8F-6d14A:19.515hw8G-6d14A:19.51 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6ei3 | PROTON-DEPENDENTOLIGOPEPTIDETRANSPORTER FAMILYPROTEIN (Xanthomonascampestris) |
no annotation | 5 | TYR A 527VAL A 141ILE A 94ILE A 132PHE A 159 | None | 1.06A | 5hw8B-6ei3A:undetectable5hw8F-6ei3A:undetectable5hw8G-6ei3A:undetectable | 5hw8B-6ei3A:13.695hw8F-6ei3A:13.695hw8G-6ei3A:13.69 |